Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer

Boyle, David P., McArt, Darragh G., Irwin, Gareth, Wilhelm-Benartzi, Charlotte, Lioe, Tong F., Sebastian, Elena, McQuaid, Stephen, Hamilton, Peter W., James, Jacqueline A., Mullan, Paul B., Catherwood, Mark A., Harkin, D. Paul and Salto-Tellez, Manuel 2014. The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer. Histopathology 65 (3) , pp. 340-352. 10.1111/his.12398

Full text not available from this repository.

Abstract

Aims The utility of p53 as a prognostic assay has been elusive. The aims of this study were to describe a novel, reproducible scoring system and assess the relationship between differential p53 immunohistochemistry (IHC) expression patterns, TP53 mutation status and patient outcomes in breast cancer. Methods and results Tissue microarrays were used to study p53 IHC expression patterns: expression was defined as extreme positive (EP), extreme negative (EN), and non‐extreme (NE; intermediate patterns). Overall survival (OS) was used to define patient outcome. A representative subgroup (n = 30) showing the various p53 immunophenotypes was analysed for TP53 hotspot mutation status (exons 4–9). Extreme expression of any type occurred in 176 of 288 (61%) cases. As compared with NE expression, EP expression was significantly associated (P = 0.039) with poorer OS. In addition, as compared with NE expression, EN expression was associated (P = 0.059) with poorer OS. Combining cases showing either EP or EN expression better predicted OS than either pattern alone (P = 0.028). This combination immunophenotype was significant in univariate but not multivariate analysis. In subgroup analysis, six substitution exon mutations were detected, all corresponding to extreme IHC phenotypes. Five missense mutations corresponded to EP staining, and the nonsense mutation corresponded to EN staining. No mutations were detected in the NE group. Conclusions Patients with extreme p53 IHC expression have a worse OS than those with NE expression. Accounting for EN as well as EP expression improves the prognostic impact. Extreme expression positively correlates with nodal stage and histological grade, and negatively with hormone receptor status. Extreme expression may relate to specific mutational status.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
Publisher: Wiley-Blackwell
ISSN: 0309-0167
Date of Acceptance: 19 February 2014
Last Modified: 04 Jun 2019 15:38
URI: http://orca.cf.ac.uk/id/eprint/96188

Citation Data

Cited 36 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item